Identifying a wide range of mutations in the <i>BRAF</i> gene for prescribing targeted drugs for melanoma treatment
Melanoma is an aggressive malignancy of the skin and mucosa of neuroepithelial nature, heterogeneous both in phenotype and molecular genetic characteristics, with a high risk of progression and a steadily increasing incidence of about 5% a year. The development of melanoma is due to both external (U...
Saved in:
Main Authors: | A. N. Toropovskiy, A. G. Nikitin, A. V. Solov'ev, R. M. Khuzina, O. N. Pavlova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Private institution educational organization of higher education "Medical University "ReaViz"
2023-03-01
|
Series: | Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье |
Subjects: | |
Online Access: | https://vestnik.reaviz.ru/jour/article/view/607 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systemic therapy of skin metastatic melanoma with BRAF gene mutation
by: Yu. S. Shakh-Paronyants, et al.
Published: (2023-03-01) -
Association between braf gene mutation status and clinical-morphological features of cutaneous melanoma
by: O. I. Kit, et al.
Published: (2016-06-01) -
The relationship of clinical and morphological parameters with the BRAF status of the tumor in patients with stage I skin melanoma
by: K. S. Titov, et al.
Published: (2024-09-01) -
The combination of mutations in BRAF and NRAS genes within a one tumor in patients with cutaneous melanoma
by: M. B. Aksenenko, et al.
Published: (2019-10-01) -
MelCher5k/<i>BRAF</i><sup>+</sup> subcutaneous human melanoma xenograft with CD20 expression
by: I. N. Mikhaylova, et al.
Published: (2025-06-01)